1,073 results on '"Silverman, Earl"'
Search Results
52. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality?
53. Looking Back and Marching Forward: New Features in 2022
54. Timing of Childhood‐Onset Systemic Lupus Erythematosus Diagnosis Relative to Menarche and the Impact on Final Adult Height
55. Transmission disequilibrium analysis of whole genome data in childhood-onset systemic lupus erythematosus
56. Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus
57. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
58. Brief Report: Endothelial Progenitor Cell Phenotype and Function Are Impaired in Childhood-Onset Systemic Lupus Erythematosus
59. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
60. 25 - Neonatal Lupus Erythematosus
61. 1116 Long-term ocular safety of hydroxychloroquine in patients with childhood-onset SLE (cSLE) followed into adulthood
62. 1501 Genetics of age at systemic lupus erythematosus diagnosis
63. Clinical and Laboratory Characteristics and Long-Term Outcome of Pediatric Systemic Lupus Erythematosus: A Longitudinal Study
64. Course, complications, and outcome of juvenile arthritis–related uveitis
65. sj-pdf-3-lup-10.1177_09612033211018504 - Supplemental material for Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus
66. sj-pdf-2-lup-10.1177_09612033211018504 - Supplemental material for Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus
67. sj-pdf-1-lup-10.1177_09612033211018504 - Supplemental material for Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus
68. Chest CT findings in pediatric Wegener’s granulomatosis
69. The 1000 Canadian faces of systemic lupus erythematosus: effect of ethnicity on baseline pediatric data
70. Quality of life in adolescents with recently diagnosed childhood-onset systemic lupus erythematosus
71. The role of antimalarials in lupus nephritis: a review
72. Systemic Lupus Erythematosus
73. Ghost busting—taking the sheet off the ghost
74. Evaluation of self-report screening measures in the detection of depressive and anxiety disorders among children and adolescents with systemic lupus erythematosus
75. Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multiethnic Cohort
76. Effect of autoimmune diseases on cognitive function
77. Leflunomide or methotrexate for juvenile rheumatoid arthritis
78. A153: Long-term Outcomes of Childhood-Onset Systemic Lupus Erythematosus in Adulthood
79. A149: Does Prenatal Exposure to Antimalarial Decrease the Risk of Neonatal Lupus: a Bayesian Perspective
80. Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study
81. NEONATAL LUPUS ERYTHEMATOSUS
82. CONTRIBUTORS
83. SYSTEMIC LUPUS ERYTHEMATOSUS
84. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood
85. Cytomegalovirus infection in childhood-onset systemic lupus erythematosus
86. Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial.: 1597
87. Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients
88. Effects of Transplacental Dexamethasone Therapy on Fetal Immune-Mediated Complete Heart Block
89. The role of antimalarial agents in the treatment of SLE and lupus nephritis
90. Low bone mineral density is present in newly diagnosed paediatric systemic lupus erythematosus patients
91. Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis
92. Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus
93. Etanercept in children with polyarticular juvenile rheumatoid arthritis
94. Prevalence and burden of pediatric-onset systemic lupus erythematosus
95. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
96. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus
97. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity
98. Predictors of Early Inactive Disease in a Juvenile Idiopathic Arthritis Cohort: Results of a Canadian Multicenter, Prospective Inception Cohort Study
99. Adipokines as novel biomarkers in paediatric systemic lupus erythematosus
100. Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.